NCT06352736 Status of Disease Burden of Lower Urinary Tract Symptoms in Chinese Male Community
| NCT ID | NCT06352736 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese PLA General Hospital |
| Condition | Lower Urinary Tract Symptoms |
| Study Type | OBSERVATIONAL |
| Enrollment | 12,567 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 12,567 participants in total. It began in 2023-06-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study, set up as a cross-sectional survey, seeks to delve into the disease burden and the demographic specifics of lower urinary tract symptoms (LUTS) among the male community in China. The investigators's main aim is to map out the overall and age-specific prevalence rates of LUTS within the Chinese male population. These insights are critical for understanding the public health dimensions of this condition. Moreover, the investigators plan to investigate several secondary aspects: the correlation of LUTS prevalence with factors like urbanization levels (rural vs. urban), geographical distribution, and lifestyle choices. Another significant focus will involve examining the treatment landscape for LUTS, looking at the portion of sufferers receiving treatment, the diversity in treatment durations, and the types of treatments employed (medication vs. surgery). This comprehensive analysis is intended to shed light on the prevailing management strategies for LUTS in China. The study is scheduled to unfold over 36 months and will comprise three pivotal phases: initial preparations, recruitment of subjects and collection of data, followed by the analysis of data and compilation of reports. The investigators will employ a range of methods such as questionnaires, physical exams, laboratory tests, imaging, and other medical evaluations to amass extensive data. This will allow the investigators to evaluate the prevalence of LUTS across various age groups among men and address the current gaps in epidemiological understanding.
Eligibility Criteria
Inclusion Criteria: 1. Mainland China, aged 40 or older, male, in 31 provincial-level administrative regions. 2. Have resided for a total of 6 months or more in the survey county (district) in the past 12 months. 3. Normal communication, cooperation during physical examination, and good cognitive ability. 4. Willing to participate in and cooperate with this study, and sign the informed consent form. Exclusion Criteria: 1. Closed communities, such as armed forces and nursing homes. 2. Individuals with mental illnesses or other conditions that prevent cooperation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06352736 clinical trial?
This trial is open to male participants only, aged 40 Years or older, studying Lower Urinary Tract Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06352736 currently recruiting?
Yes, NCT06352736 is actively recruiting participants. Contact the research team at qyuanmd@outlook.com for enrollment information.
Where is the NCT06352736 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06352736 clinical trial?
NCT06352736 is sponsored by Chinese PLA General Hospital. The trial plans to enroll 12,567 participants.